Trials / Completed
CompletedNCT03614273
Nebulized Hypertonic Saline (3%) Versus Nebulized Adrenaline for Treatment of Bronchiolitis
Nebulized Hypertonic Saline (3%) Versus Nebulized Adrenaline for Treatment of Bronchiolitis: A Randomized Control Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Maulana Azad Medical College · Academic / Other
- Sex
- All
- Age
- 1 Month – 2 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of this study was to compare the effectiveness of nebulized hypertonic saline (3%) and nebulized adrenaline in bronchiolitis. The secondary objective was to assess whether non-responders to initial therapy benefit from continuation of the same therapy. This trial was conducted at a tertiary care teaching hospital over a period of one year in children with bronchiolitis presenting to the out-patient department and emergency. After obtaining a signed informed consent from the parents, all eligible children were assessed for baseline characteristics. A complete hemogram, chest X-ray were done in all and arterial blood gas analysis where ever required. Computer generated random numbers were used for enrolment in consecutive manner and patients were randomly assigned into two groups. The first group received one dose (4ml) of nebulized hypertonic saline (3%).The second group received one dose (0.1 mg/kg) of nebulized adrenaline diluted in normal saline to make it a 4ml solution. Supportive care (nasal clearing, antipyretics, oxygenation, intravenous fluids) was done in both groups as necessary. All children were reassessed 20 minutes after one dose of nebulization using the clinical score and a child was labelled as a "responder" if he showed an improvement in the clinical severity score by atleast 3 points after 20 minutes of nebulization. Both responders and non-responders were given a repeat dose of nebulization according to the group to which the child had been randomized, if: a) Severe audible wheeze with severe respiratory distress (severity score ≥9) b) Inability to maintain saturation \>92% even on an O2 flow of 4 L/min. Non responders were given a maximum of three continuous doses of nebulization. Child was considered fit for discharge if he/she was feeding well orally, there was no need for intravenous fluids, clinical severity score ≤3 and maintaining oxygen saturation \>92% on room air for a period of more than 12 hours.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Hypertonic saline | The nebulizations were administered via an oxygen run jet nebulizer, with a flow of 6-7 litres/min. |
| DRUG | Adrenaline | The nebulizations were administered via an oxygen run jet nebulizer, with a flow of 6-7 litres/min. |
Timeline
- Start date
- 2015-03-01
- Primary completion
- 2016-02-29
- Completion
- 2016-02-29
- First posted
- 2018-08-03
- Last updated
- 2018-08-03
Locations
1 site across 1 country: India
Source: ClinicalTrials.gov record NCT03614273. Inclusion in this directory is not an endorsement.